Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Systematic reviews and meta-analyses
PRISMA checklist (Word) PRISMA flow diagram (Word)
|Full bibliographic reference||Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement.
PLoS Med. 2009; 6(7):e1000097. PMID: 19621072
BMJ. 2009; 339:b2535. PMID: 19622551
Ann Intern Med. 2009;151(4):264-269, W64. PMID: 19622511
J Clin Epidemiol. 2009;62(10):1006-1012. PMID: 19631508
Open Med. 2009;3(3);123-130. PMID: 21603045
Int J Surg. 2010;8(5):336-341. PMID: 20171303
(full-text if available)
|Full-text PDF documents of the PRISMA Statement, checklist, flow diagram and the PRISMA Explanation and Elaboration document are available from:
|Explanation and elaboration papers||Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration.
PLoS Med. 2009;6(7):e1000100. PMID: 19621070
BMJ. 2009; 339:b2700. PMID: 19622552
Ann Intern Med. 2009;151(4):W65-W94. PMID: 19622512
|Previous versions of this guideline / Guideline history||QUOROM guideline (PRISMA replaces QUOROM)|
|Relevant more generic / specialised reporting guidelines
(i.e. main generic guideline or extension to a generic guideline)
PRISMA-Equity: Welch V, Petticrew M, Tugwell P, Moher D, O'Neill J, Waters E, White H; PRISMA-Equity Bellagio group. PRISMA-Equity 2012 Extension: Reporting Guidelines for Systematic Reviews with a Focus on Health Equity. PLoS Med. 2012;9(10):e1001333. PMID: 23222917
Welch V, Petticrew M, Petkovic J, Moher D, Waters E, White H, Tugwell P; PRISMA-Equity Bellagio group. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
Int J Equity Health. 2015;14(1):92. PMID: 26450828
J Clin Epidemiol. 2015. PMID: 26348799
PRISMA-Abstracts: Beller EM, Glasziou PP, Altman DG, Hopewell S, Bastian H, Chalmers I, Gøtzsche PC, Lasserson T, Tovey D; PRISMA for Abstracts Group. PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts. PLoS Med. 2013;10(4):e1001419. PMID: 23585737
PRISMA-P: Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. PMID: 25554246
PRISMA-IPD: Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, Tierney JF; PRISMA-IPD Development Group. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement. JAMA. 2015;313(16):1657-1665. PMID: 25919529
PRISMA extension for network meta-analyses: Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP, Mulrow C, Catalá-López F, Gøtzsche PC, Dickersin K, Boutron I, Altman DG, Moher D. The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations. Ann Intern Med. 2015;162(11):777-784. PMID: 26030634
PRISMA-harms: Zorzela L, Loke YK, Ioannidis JP, Golder S, Santaguida P, Altman DG, Moher D, Vohra S; PRISMA harms group. PRISMA harms checklist: improving harms reporting in systematic reviews. BMJ. 2016;352:i157. PMID: 26830668
|Reporting guideline website URL||http://www.prisma-statement.org/|
|Reporting guideline acronym||PRISMA|
|Study design||Systematic reviews/Meta-analyses/HTA|
|Applies to the whole report or to individual sections of the report?||Whole report|
|Availability in additional languages||A full-text copy of the PRISMA Statement is available as a PDF document in Spanish, Italian, Portuguese and Chinese.
The PRISMA checklist is available in Korean as a PDF, in Russian as a PDF document, in Portuguese as a PDF and Word document and in Italian as a PDF document.
The PRISMA flow diagram is available in Korean as a PDF, in Russian as a PDF document, in Portuguese as a PDF and Word document and in Italian as a PDF document.
The PRISMA Explanation and Elaboration document is available as a PDF document in Italian.
Visit our translations page to find out what other reporting guidelines are available in languages other than English: reporting guideline translations
|Additional information||Guidance for developing protocols for systematic reviews and meta-analyses is provided in the PRISMA-P Statement. For further details please visit: PRISMA-P Statement
The PRISMA flow diagram has recently been adapted for use in Cochrane systematic review updates. Further details are available in the article below:
Stovold E, Beecher D, Foxlee R, Noel-Storr A. Study flow diagrams in Cochrane systematic review updates: an adapted PRISMA flow diagram. Syst Rev. 2014 May 29;3:54. PMID: 24886533
|Record last updated on||August 18, 2016|
|Diagnostic / prognostic studies||STARD||TRIPOD|
|Quality improvement studies||SQUIRE|
|Animal pre-clinical studies||ARRIVE|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.
For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.
Visit our Help page for information about searching for reporting guidelines and for general information about using our website.
Our full catalogue of reporting guidelines is available to download as a PDF: Reporting Guideline Catalogue May 2014.